Your Article Summary
See Latest ArticlesTrends in Colorectal Cancer Test Use in the Medicare Population, 1998–2005
American Journal of Preventive Medicine, 06/26/09
Schenck AP et al. - CRC test-use rates in the Medicare population are low. Disparities are apparent by age, race/ethnicity, gender, disability, income, and geographic residence. Much work remains to be done to increase testing to acceptable levels.
Related Articles
Are gender differences in colorectal cancer screening rates due to differences in self-reporting?
Preventive Medicine, 11/12/09
Relevance Score: 87%
Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 85%
Aspirin use associated with lower colorectal cancer mortality
American Pharmacists Association, 10/14/09
Relevance Score: 83%
Are U.S. cancer screening test patterns consistent with guideline recommendations with respect to the age of screening initiation
BMC Health Services Research, 10/14/09
Relevance Score: 82%
Aspirin as Colorectal Cancer Adjuvant Therapy
Gastroenterology, 10/05/09
Relevance Score: 82%
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/30/09
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Vascular Health and Risk Management, 11/30/09
Effectiveness of Public Report Cards for Improving the Quality of Cardiac Care: The EFFECT Study: A Randomized Trial
JAMA, 11/25/09